410 related articles for article (PubMed ID: 15491964)
1. Potential laboratory misdiagnosis of hemophilia and von Willebrand disorder owing to cold activation of blood samples for testing.
Favaloro EJ; Soltani S; McDonald J
Am J Clin Pathol; 2004 Nov; 122(5):686-92. PubMed ID: 15491964
[TBL] [Abstract][Full Text] [Related]
2. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078
[TBL] [Abstract][Full Text] [Related]
3. Loss of factor VIII and von Willebrand factor activities during cold storage of whole blood is reversed by rewarming.
Refaai MA; Van Cott EM; Lukoszyk M; Hughes J; Eby CS
Lab Hematol; 2006; 12(2):99-102. PubMed ID: 16751138
[TBL] [Abstract][Full Text] [Related]
4. Laboratory diagnosis of von Willebrand disorder. Current practice in the southern hemisphere.
Favaloro EJ; Bonar R; Sioufi J; Hertzberg M; Street A; Lloyd J; Marsden K;
Am J Clin Pathol; 2003 Jun; 119(6):882-93. PubMed ID: 12817437
[TBL] [Abstract][Full Text] [Related]
5. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis.
Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L; Favaloro JW
Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741
[TBL] [Abstract][Full Text] [Related]
6. Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel.
Favaloro EJ; Smith J; Petinos P; Hertzberg M; Koutts J
Thromb Haemost; 1999 Oct; 82(4):1276-82. PubMed ID: 10544913
[TBL] [Abstract][Full Text] [Related]
7. Lower limit of assay sensitivity: an under-recognised and significant problem in von Willebrand disease identification and classification.
Favaloro EJ; Bonar R; Marsden K
Clin Lab Sci; 2008; 21(3):178-83. PubMed ID: 18678140
[TBL] [Abstract][Full Text] [Related]
8. Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586).
Hubbard AR; Rigsby P; Barrowcliffe TW
Thromb Haemost; 2001 Apr; 85(4):634-8. PubMed ID: 11341497
[TBL] [Abstract][Full Text] [Related]
9. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
[TBL] [Abstract][Full Text] [Related]
10. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
11. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
12. Laboratory diagnosis of von Willebrand disorder: use of multiple functional assays reduces diagnostic error rates.
Favaloro EJ; Bonar R; Kershaw G; Sioufi J; Thom J; Baker R; Hertzberg M; Street A; Lloyd J; Marsden K;
Lab Hematol; 2005; 11(2):91-7. PubMed ID: 16024332
[TBL] [Abstract][Full Text] [Related]
13. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
[TBL] [Abstract][Full Text] [Related]
14. Thai national reference preparation in blood coagulation. IV. Home made reference plasma for von Willebrand's factor assay.
Talalak P; Luenee P; Opartkiattikul N; Sangtawisin V
J Med Assoc Thai; 1993 Oct; 76(10):570-5. PubMed ID: 7964228
[TBL] [Abstract][Full Text] [Related]
15. Potential misdiagnosis of von Willebrand disease and haemophilia caused by ineffective mixing of thawed plasma.
Favaloro EJ; Oliver S; Mohammed S; Ahuja M; Grzechnik E; Azimulla S; McDonald J; Lima-Oliveira G; Lippi G
Haemophilia; 2017 Sep; 23(5):e436-e443. PubMed ID: 28750474
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
[TBL] [Abstract][Full Text] [Related]
17. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
Michiels JJ; Gadisseur A; Budde U; Berneman Z; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Semin Thromb Hemost; 2005 Nov; 31(5):577-601. PubMed ID: 16276467
[TBL] [Abstract][Full Text] [Related]
18. Laboratory diagnosis of von Willebrand's disorder: quality and diagnostic improvements driven by peer review in a multilaboratory test process.
Favaloro EJ; Bonar R; Kershaw G; Sioufi J; Hertzberg M; Street A; Lloyd J; Marsden K;
Haemophilia; 2004 May; 10(3):232-42. PubMed ID: 15086320
[TBL] [Abstract][Full Text] [Related]
19. Reducing errors in identification of von Willebrand disease: the experience of the royal college of pathologists of australasia quality assurance program.
Favaloro EJ; Bonar R; Kershaw G; Sioufi J; Baker R; Hertzberg M; Street A; Marsden K
Semin Thromb Hemost; 2006 Jul; 32(5):505-13. PubMed ID: 16862524
[TBL] [Abstract][Full Text] [Related]
20. Laboratory monitoring of therapy in von Willebrand disease: efficacy of the PFA-100 and von Willebrand factor:collagen-binding activity as coupled strategies.
Favaloro EJ
Semin Thromb Hemost; 2006 Sep; 32(6):566-76. PubMed ID: 16977567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]